Financial Strategies Acquisition Corp.
Status: Live Deal
U=S+W+R
W=S@11.5
R=S/10
IPO Proceeds, $M | $100.05M |
---|---|
IPO Date | Dec 10, 2021 |
CEO | Alexander Schinzing |
Left Lead | I-Bankers Securities |
IPO Cash in Trust | 101.0% |
SPAC Tenor | 12 + 12 |
IPO Sector |
Financial
FinTech and financial services |
IPO Geography | Global |
Target Company | Austin Biosciences |
Deal Announced | Feb 13, 2023 |
Deal Size, $M | TBD |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Dec 9, 2022 |
FXCO
FXCOU
FXCOW
FXCOR
Price | $11.10 |
---|---|
Last closing price | $11.00 |
H/L, today | $11.00 / $11.00 |
H/L, 52-week | $10.06 / $11.10 |
Volume, today | 500 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | $0.07 |
---|---|
Last closing price | $0.00 |
High/low price, today | $0.00 / $0.00 |
High/low price, 52-week | $0.00 / $0.30 |
Volume, today | 60,492 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Financial Strategies Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 25 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Alexander Schinzing | 50 | CEO |
Horst Rzepka | 54 | CFO, Director |
Timo Vainionpää | 62 | Chairman, Director |
Jamie Khurshid | 45 | Director |
Daniel Minkowitz | 43 | Director |
Stefan Nolte | 59 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
I-Bankers Securities | BR | 8,700,000 | units |
8,700,000 | units | ||
Up-Front UW fee | 2.00 | % | |
BCMA | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 25 filings.